FDA Approved: OPDUALAG — Original Application (E.R. Squibb & Sons, L.L.C.)

View source ↗

Summary

FDA approved Opdualag (nivolumab and relatlimab-rmbw) based on the original application for unresectable or metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Opdualag (relatlimab and nivolumab)

Snippet

ORIG AP for OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW)